Who will hit the $11B jackpot?

This week has been one of the quietest in recent memory but that doesn't mean there weren't some big headlines. From the Department of Defense opening its $11 billion EHR modernization contract to bids to an FBI alert regarding cyberthreats, there's never a dull moment in health IT.

According to the DoD's request for proposals, the project aims to replace outdated DoD legacy healthcare systems, including the Armed Forces Health Longitudinal Technology Application (DoD's current EHR system), the inpatient Composite Health Care System and several components of the Theater Medical Information Program-Joint. DoD officials expect to select the vendor in the third quarter of FY 2015.  

"We are not just buying an off-the-shelf system; we're really looking to modernize how the department delivers healthcare," said Christopher Miller, program executive officer, Defense Healthcare Management Systems, in a press statement announcing the RFP. "Ultimately, program success will result in continued improvement in patient safety, quality of care and readiness of forces worldwide."  

Who do you think will get the big contract? Epic and IBM are working together as are Computer Sciences, Allscripts and HP and a third joint venture announced over the summer involves Cerner, Leidos and Accenture.

Beth Walsh

Clinical Innovation + Technology editor 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.